LYL1 and acute myeloid leukemia: Compared to healthy controls, t(8;21) AML samples presented increased chromatin accessibility at loci of TCF12, LYL1, and RUNX1 (Fig. 1G), indicating the pathogenesis of AML1-ETO in t(8;21) AML.